A pleasure to talk about our research today with the amazing volunteers at St John’s ambulance in aid of @cancerresearchuk.org

Apply for Multiplex Assays of Variant Effects training by 18 August! ⏰ Join our experts to learn how to strengthen your genetic disease research or clinical work using MAVE data. 🧬 Financial assistance available💸 📎Find out more: bit.ly/3EW3lh4 #MAVE25 #VariantInterpretation

Coming up in September! ➡️Christina Kajba @ckajba.bsky.social & Michael Herger @michaelherger.bsky.social — pooled prime editing screens in haploid human cells ➡️Jon Acosta — multiplexed in vivo base editing screens #GeneticVariants #PrimeEditing ℹ️https://www.varianteffect.org/seminar-series/

Natural molecular glues spur next-gen small molecules for ‘undruggable’ targets www.nature.com/articles/s41...

Looking to combine ML and functional genomics to tackle cancer drug resistance? Exciting job opening at the Sanger! sanger.wd103.myworkdayjobs.com/en-US/Wellco...

@mattcoelho.bsky.social at #VariantEffect25

🚨 Excited to share our latest preprint! @mgarnett.bsky.social @mattcoelho.bsky.social We introduce BEstimate, a flexible, comprehensive tool for designing and interpreting CRISPR-based editing experiments. #CRISPR #BEstimate #BaseEditor

Magdalena Strauss at #VariantEffect25

Come and join us! We’re hiring a new Group Leader in Generative Biology at the @sangerinstitute.bsky.social Building AI models or the data to train them? Core funding of >$130M a year for a faculty of ~30. www.nature.com/naturecareer... acrobat.adobe.com/id/urn:aaid:... pls RT!

Excited to announce our preprint today @biorxivpreprint.bsky.social Using functional genomics, we map the genetic determinants cancer cell sensitivity to tumour-reactive T cells: www.biorxiv.org/content/10.1...

less than one week remaining to apply 👇

New Gordon Research Conference Alert: Synthetic Lethality Approaches in Oncology. www.grc.org/synthetic-le.... Join us 20-25th July 2025 for an intimate meeting with thought leaders in the field. Great for networking and opportunities for early career scientists to present their research.

Excited to announce that we're recruiting a Staff scientist at the Sanger Institute to investigate drug resistance mechanisms in cancer using gene editing. Interested? Apply here: sanger.wd103.myworkdayjobs.com/en-US/Wellco...

Thrilled to share new work led by @jieyang437.bsky.social in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre rdcu.be/eci1U

Today in BJC Reports, we summarise the outcomes from a multidisciplinary workshop focused on addressing cancer drug resistance. www.nature.com/articles/s44...

Thrilled to share our first dive into generative models, integrating 7 distinct omics to generate a complete Synthetic Cancer Dependency Map for +1,500 cancer cell lines! Excited for what’s ahead. rdcu.be/d1TgQ #GarnettLab #CMRI #ProCan #INESC-ID #IST @naturecomms.bsky.social

last couple days to apply (for free! from anywhere in the world!) to the Sanger 2025 PhD Programme — Deadline: 28th November 2024 (09:00 GMT) For more info, visit www.sanger.ac.uk/about/study/...

Applications are now open for the Sanger prize! A 3 month placement - undergraduates from low and middle income countries encouraged to apply www.sanger.ac.uk/about/the-sa...